论文部分内容阅读
Objective Gastric cancer (GC) is a diffuse disease with extensively poor prognosis.To guide clinicians in selecting treatment options for GC patients, reliable markers predictive of poor clinical outcome are desirable.This study analyzed the correlation of RAP1B, HIF-1α and MMP2 in GC and their relationships to clinicopathologic features and survival.